Roche Holding Ag Stock Net Income
| RO Stock | CHF 366.20 0.40 0.11% |
As of the 6th of February, Roche Holding holds the Coefficient Of Variation of 302.27, risk adjusted performance of 0.2532, and Semi Deviation of 0.501. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Roche Holding, as well as the relationship between them. Please check Roche Holding AG mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if Roche Holding AG is priced some-what accurately, providing market reflects its current price of 366.2 per share.
Roche Holding Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 4.8181 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 12.9 B | 9.8 B | |
| Net Income From Continuing Ops | 13.8 B | 12.9 B | |
| Net Income Applicable To Common Shares | 12.9 B | 12.3 B | |
| Net Income Per Share | 16.18 | 8.21 | |
| Net Income Per E B T | 0.76 | 0.85 |
Roche | Net Income |
The evolution of Net Income for Roche Holding AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Roche Holding compares to historical norms and industry peers.
Latest Roche Holding's Net Income Growth Pattern
Below is the plot of the Net Income of Roche Holding AG over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Roche Holding AG financial statement analysis. It represents the amount of money remaining after all of Roche Holding AG operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Roche Holding's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Roche Holding's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 12.88 B | 10 Years Trend |
|
Net Income |
| Timeline |
Roche Net Income Regression Statistics
| Arithmetic Mean | 10,449,189,496 | |
| Geometric Mean | 10,117,237,484 | |
| Coefficient Of Variation | 23.90 | |
| Mean Deviation | 1,951,939,298 | |
| Median | 9,576,000,000 | |
| Standard Deviation | 2,497,488,468 | |
| Sample Variance | 6237448.6T | |
| Range | 9.9B | |
| R-Value | 0.50 | |
| Mean Square Error | 4968253.1T | |
| R-Squared | 0.25 | |
| Significance | 0.04 | |
| Slope | 248,896,499 | |
| Total Sum of Squares | 99799178.4T |
Roche Net Income History
Roche Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Roche Holding is extremely important. It helps to project a fair market value of Roche Stock properly, considering its historical fundamentals such as Net Income. Since Roche Holding's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Roche Holding's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Roche Holding's interrelated accounts and indicators.
Click cells to compare fundamentals
Roche Holding 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Roche Holding's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Roche Holding.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Roche Holding on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Roche Holding AG or generate 0.0% return on investment in Roche Holding over 90 days. Roche Holding is related to or competes with Novartis, COSMO Pharmaceuticals, Siegfried Holding, Sonova H, Galenica Sante, Alcon AG, and Tecan Group. Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, A... More
Roche Holding Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Roche Holding's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Roche Holding AG upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.05 | |||
| Information Ratio | 0.2982 | |||
| Maximum Drawdown | 9.82 | |||
| Value At Risk | (1.24) | |||
| Potential Upside | 2.73 |
Roche Holding Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Roche Holding's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Roche Holding's standard deviation. In reality, there are many statistical measures that can use Roche Holding historical prices to predict the future Roche Holding's volatility.| Risk Adjusted Performance | 0.2532 | |||
| Jensen Alpha | 0.4422 | |||
| Total Risk Alpha | 0.382 | |||
| Sortino Ratio | 0.3906 | |||
| Treynor Ratio | 3.79 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Roche Holding's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Roche Holding February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2532 | |||
| Market Risk Adjusted Performance | 3.8 | |||
| Mean Deviation | 0.9935 | |||
| Semi Deviation | 0.501 | |||
| Downside Deviation | 1.05 | |||
| Coefficient Of Variation | 302.27 | |||
| Standard Deviation | 1.38 | |||
| Variance | 1.9 | |||
| Information Ratio | 0.2982 | |||
| Jensen Alpha | 0.4422 | |||
| Total Risk Alpha | 0.382 | |||
| Sortino Ratio | 0.3906 | |||
| Treynor Ratio | 3.79 | |||
| Maximum Drawdown | 9.82 | |||
| Value At Risk | (1.24) | |||
| Potential Upside | 2.73 | |||
| Downside Variance | 1.11 | |||
| Semi Variance | 0.251 | |||
| Expected Short fall | (1.17) | |||
| Skewness | 1.04 | |||
| Kurtosis | 4.61 |
Roche Holding AG Backtested Returns
Roche Holding appears to be very steady, given 3 months investment horizon. Roche Holding AG maintains Sharpe Ratio (i.e., Efficiency) of 0.3, which implies the firm had a 0.3 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Roche Holding AG, which you can use to evaluate the volatility of the company. Please evaluate Roche Holding's Semi Deviation of 0.501, risk adjusted performance of 0.2532, and Coefficient Of Variation of 302.27 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Roche Holding holds a performance score of 23. The company holds a Beta of 0.12, which implies not very significant fluctuations relative to the market. As returns on the market increase, Roche Holding's returns are expected to increase less than the market. However, during the bear market, the loss of holding Roche Holding is expected to be smaller as well. Please check Roche Holding's downside variance, and the relationship between the total risk alpha and daily balance of power , to make a quick decision on whether Roche Holding's historical price patterns will revert.
Auto-correlation | 0.83 |
Very good predictability
Roche Holding AG has very good predictability. Overlapping area represents the amount of predictability between Roche Holding time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Roche Holding AG price movement. The serial correlation of 0.83 indicates that around 83.0% of current Roche Holding price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.83 | |
| Spearman Rank Test | 0.8 | |
| Residual Average | 0.0 | |
| Price Variance | 77.56 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Roche Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Roche Holding AG reported net income of 12.88 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all Switzerland stocks is significantly lower than that of the firm.
Roche Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roche Holding's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Roche Holding could also be used in its relative valuation, which is a method of valuing Roche Holding by comparing valuation metrics of similar companies.Roche Holding is currently under evaluation in net income category among its peers.
Roche Fundamentals
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.30 % | ||||
| Current Valuation | 305.25 B | ||||
| Shares Outstanding | 106.69 M | ||||
| Shares Owned By Insiders | 72.83 % | ||||
| Shares Owned By Institutions | 9.70 % | ||||
| Price To Earning | 22.52 X | ||||
| Price To Book | 8.63 X | ||||
| Price To Sales | 4.54 X | ||||
| Revenue | 61.52 B | ||||
| Gross Profit | 47.19 B | ||||
| EBITDA | 18.32 B | ||||
| Net Income | 12.88 B | ||||
| Cash And Equivalents | 1.51 B | ||||
| Cash Per Share | 8.50 X | ||||
| Total Debt | 31.64 B | ||||
| Debt To Equity | 1.00 % | ||||
| Current Ratio | 1.11 X | ||||
| Book Value Per Share | 42.48 X | ||||
| Cash Flow From Operations | 17.83 B | ||||
| Earnings Per Share | 16.04 X | ||||
| Price To Earnings To Growth | 0.93 X | ||||
| Target Price | 360.0 | ||||
| Number Of Employees | 103.25 K | ||||
| Beta | 0.2 | ||||
| Market Capitalization | 287.54 B | ||||
| Total Asset | 100.7 B | ||||
| Retained Earnings | 48.84 B | ||||
| Working Capital | 10.73 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 2.94 % | ||||
| Net Asset | 100.7 B | ||||
| Last Dividend Paid | 9.8 |
About Roche Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roche Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roche Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roche Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Roche Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.